Long-Term Benefits and Safety of Systemic Psoriasis Therapy: German Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Adalimumab; Ciclosporin; Efalizumab; Etanercept; Fumaric acid; Golimumab; Infliximab; Methotrexate; Ustekinumab
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms PsoBest
- 17 May 2019 Biomarkers information updated
- 09 May 2013 New trial record